Table 1. Comparison of characteristics of patients undergoing treatment with ACEI or ARB.
ACEI: Angiotensin-converting enzyme inhibitor, ARB: Angiotensin receptor blocker, CLD: Chronic liver disease, CKD: Chronic kidney disease, DM: Diabetes mellitus, NS: non-significant, MI: Myocardial Infarction
| Demographics of participants | ACEI group (n=14,891) | ARB group (n=19,112) | P-value |
| Age at the time of diagnosis of hypertension (Mean ± Standard Deviation) | 49 ± 11 | 50 ± 12 | NS |
| Male | 7,854 (52.74%) | 10,781 (56.41%) | NS |
| Smokers | 5,021 (33.7%) | 6,812 (35.65%) | NS |
| Comorbidity | |||
| DM | 7,652 (51.39%) | 10,856 (56.80%) | NS |
| CLD | 1,101 (7.39%) | 1,651 (8.64%) | NS |
| CKD | 2,022 (13.58%) | 2,401 (12.56%) | NS |
| Hyperlipidemia | 6,078 (40.82%) | 7,998 (41.85%) | NS |
| Asthma | 782 (5.25%) | 1,021 (5.34%) | NS |
| Stroke | 515 (3.46%) | 600 (3.14%) | NS |
| MI | 1,254 (8.42%) | 1,601 (8.38%) | NS |
| Concomitant Medications for Hypertension | |||
| Alpha blockers | 131 (8.81%) | 1,721 (9.00%) | NS |
| Beta blockers | 6,052 (40.64%) | 8,502 (44.49%) | NS |
| Calcium channel blockers | 10,112 (67.91%) | 13,281 (69.49%) | NS |
| Diuretics | 6,565 (44.09%) | 8,215 (42.98%) | NS |